Tom Gayner acquired 2.87M Novo Nordisk shares worth $123M. That's 0.67% of their equity portfolio (33rd largest holding). The first Novo Nordisk trade was made in Q4 2009. Since then Tom Gayner bought shares seven more times and sold shares on twelve occasions. The investor's estimated purchase price is $138M, resulting in a loss of 11%.